NOS2 and glioma: Aberrant nitric oxide synthase 2 (NOS2) expression and its enzymatic product nitric oxide (NO), which play a crucial role in the pathophysiology of several inflammatory disorders, have been implicated in the development, growth and progression of several human malignant tumors, including glioma [20,21,22].